HARMONY BIOSCIENCES HLDGS IN's ticker is HRMY and the CUSIP is 413197104. A total of 202 filers reported holding HARMONY BIOSCIENCES HLDGS IN in Q3 2023. The put-call ratio across all filers is 0.36 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $447 | -5.9% | 13,647 | +1.1% | 0.00% | 0.0% |
| Q2 2023 | $475 | -90.4% | 13,503 | -91.1% | 0.00% | -85.7% |
| Q1 2023 | $4,951 | -56.3% | 151,645 | -26.2% | 0.01% | -56.2% |
| Q4 2022 | $11,326 | -99.9% | 205,550 | +11.7% | 0.02% | +33.3% |
| Q3 2022 | $8,147,000 | +63.2% | 183,941 | +79.7% | 0.01% | +71.4% |
| Q2 2022 | $4,993,000 | +485.3% | 102,376 | +484.1% | 0.01% | +600.0% |
| Q1 2022 | $853,000 | +24.3% | 17,526 | +8.9% | 0.00% | 0.0% |
| Q4 2021 | $686,000 | +11.0% | 16,088 | -0.3% | 0.00% | 0.0% |
| Q3 2021 | $618,000 | +13.8% | 16,131 | -16.2% | 0.00% | 0.0% |
| Q2 2021 | $543,000 | +157.3% | 19,251 | +200.8% | 0.00% | – |
| Q1 2021 | $211,000 | +66.1% | 6,400 | +82.9% | 0.00% | – |
| Q4 2020 | $127,000 | – | 3,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Valor Management LLC | 11,218,033 | $366,268,777 | 96.46% |
| venBio Partners LLC | 1,035,396 | $33,805,679 | 18.74% |
| Nan Fung Group Holdings Ltd | 368,665 | $12,036,912 | 8.19% |
| Vivo Capital, LLC | 2,606,247 | $85,093,965 | 5.90% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 570,500 | $18,621,120 | 5.20% |
| ASHFORD CAPITAL MANAGEMENT INC | 445,418 | $14,542,898 | 2.18% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 678,715 | $22,160,045 | 2.07% |
| TANG CAPITAL MANAGEMENT LLC | 321,200 | $10,487,180 | 1.56% |
| AlphaCentric Advisors LLC | 67,500 | $2,203,875 | 1.52% |
| Paradiem, LLC | 66,995 | $2,187,387 | 0.68% |